Evidence map›Paper›PMID 31021728›Full record

ArticleCirculation research2019

Hippo and Hyperplasia.

Allison C Ostriker, Kathleen A Martin

Abstract readEditorialComment
PubMed Full text at PMC Publisher
In one paragraph

Article in Circulation research, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Review
  2. Review
  3. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

2 authors.

Allison C OstrikerFrom the Departments of Medicine and Pharmacology, Yale University School of Medicine, New Haven, CT.
Kathleen A MartinFrom the Departments of Medicine and Pharmacology, Yale University School of Medicine, New Haven, CT.

Funding

Novel targets of rapamycin and Akt in vascular smooth muscle cell differentiationR01HL091013 · NHLBI · YALE UNIVERSITY · PI MARTIN, KATHLEEN ANN · 2008 to 2017
$4.1M
Novel insights into intimal hyperplasia in cardiac allograft vasculopathyR01HL142090 · NHLBI · YALE UNIVERSITY · PI MARTIN, KATHLEEN ANN · 2018 to 2021
$2.4M
Coordinated regulation of vascular smooth muscle phenotype by p300, CBP, and TET2R01HL146101 · NHLBI · YALE UNIVERSITY · PI GALLAGHER, PATRICK G, MARTIN, KATHLEEN ANN · 2019 to 2022
$2.2M
Epigenetic control of vascular smooth muscle in cardiovascular diseaseR01HL119529 · NHLBI · YALE UNIVERSITY · PI MARTIN, KATHLEEN ANN · 2014 to 2017
$1.7M
NHLBI NIH HHS R01 HL091013NHLBI NIH HHS R01 HL119529NHLBI NIH HHS R01 HL142090NHLBI NIH HHS R01 HL146101
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

GlutamineTranscription FactorsAmino Acid Transport System ASCCell ProliferationDNA-Binding ProteinsHippo Signaling PathwayHumansHyperplasiaMinor Histocompatibility AntigensMyocytes, Smooth MuscleNuclear ProteinsProtein Serine-Threonine KinasesTEA Domain Transcription FactorsAmino Acid Transport System ASCDNA-Binding ProteinsGlutamineMinor Histocompatibility AntigensNuclear ProteinsProtein Serine-Threonine KinasesSLC1A5 protein, humanTEAD1 protein, humanTEA Domain Transcription FactorsTranscription FactorsangioplastyEditorialsextracellular matrixhyperplasiasignal transductiontranscription factors

Identifiers

PMID31021728
PMCPMC7081792

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.